Annual rates of skeletal-related events were 0499 ( 95 % CI 0454-0549 ) with ibandronic acid and 0435 ( 0393-0480 ) with zoledronic acid ; the rate ratio for skeletal-related events was 1148 ( 95 % CI 0967-1362 ) .